1 April 2026 10:00am - 11:30am EDT
Join us for an overview of a proposed update for inclusion in SDTMIG v4.0: the split of the current RS domain into RS (Disease Response to Treatment) and CC (Clinical Classifications) domains. This change reflects community feedback and aims to bring greater clarity, consistency, and ease of implementation.
In this session, CDISC experts will highlight the value of the proposed split, explain the distinction between disease‑response assessments and clinical classification instruments, and share what this update means for future SDTM practices.
We look forward to your participation and perspectives!
Presenters
- Dianna DiRusso | CDISC
- Jordan Li | Merck
- Melanie Paules | Takeda
- Maria Sekac | Merck